Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for ...GlobeNewswire via Yahoo! FinanceApr 14 6:10 AM
Austin, Texas, April 14, 2015-- Xeris Pharmaceuticals, Inc., an Austin-based, emerging biopharmaceutical company developing patient-friendly injectable treatments for diabetes and other diseases, was awarded ...
Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental and Craniofacial Research of ...Business Wire via Yahoo! FinanceApr 13 7:51 AM
Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research Phase II grant, under Award Number R44DE024456-02, from the National Institute of Dental & Craniofacial Research of the National Institutes of Health .
HealthMyne, Inc. Receives Phase II SBIR Grant to Develop a Novel Imaging and Analytics Platform for OncologyBusiness Wire via Yahoo! FinanceApr 07 5:00 AM
HealthMyne, Inc., an early stage healthcare informatics company focused on bringing evidence-based imaging analysis to the point of care, received a prestigious Phase II Small Business Innovation Research grant from the National Science Foundation .
- SpaceRefApr 15 15:33 PM
NASA Selects American Small Business and Research Institution Projects for Further Development
DiscoveryBioMed, Inc. is awarded a new Phase 2 SBIR grant award to develop new medicines to fight the diabetes and ...Business Wire via Yahoo! FinanceApr 08 6:00 AM
DiscoveryBioMed, Inc. has learned in recent days that it has been awarded a $1.61M Phase 2 Small Business Innovation Research grant award from the National Institutes of Health and its National Institute of Diabetes, Digestive and Kidney Diseases to develop novel ‘first in class’ small molecule drugs to fight multiple disease abnormalities caused by high blood sugar and high blood fat such as ...
Immunomic Therapeutics, Inc. Awarded SBIR Grant From NIH for Nanoplasmid Peanut Allergy Vaccine DevelopmentGlobeNewswire via Yahoo! FinanceMar 31 6:40 AM
HERSHEY, Pa. and ROCKVILLE, Md. -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that ...
- PR Newswire via Yahoo! FinanceApr 14 7:00 AM
This project will substantially increase the availability of doctors using ultrasound imaging to insert needles into the body, thereby increasing efficiencies and reducing adverse outcomes. A clinical collaboration with Dr. Paul Bigeleisen, Professor of Anesthesiology in the University of Maryland Department of Anesthesiology, will test the new device as part of the SBIR award. The SBIR Award ...
- The Aero-News NetworkApr 20 2:13 AM
Nearly 150 Proposals Will Move Forward Into Contract Negotiations NASA has selected 149 research and technology proposals from American small businesses and research institutions that will enable NASA's future missions into the solar system and beyond while benefiting America's technology-driven economy right here on Earth.
- SpaceDailyApr 02 20:59 PM
The U.S. Air Force reports it is providing nearly $1.5 million in SBIR funding for development and maturation of sense-and-avoid technology for remotely piloted aircraft.
- Marketwired via Yahoo! FinanceApr 21 6:30 AM
SHAL Technologies, an emerging biotech company in the San Francisco Bay Area, has been awarded a $1.5M Phase II SBIR grant by the National Cancer Institute of NIH to complete the preclinical testing of ...
- related to SBIR